Nad+ Research Compound
Nicotinamide adenine dinucleotide (NAD+) is an essential pyridine nucleotide coenzyme involved in fundamental cellular bioenergetics, redox homeostasis, and enzymatic signaling. PX1 Research provides high-purity NAD+ research compound exclusively for laboratory research use, supporting rigorous in vitro and preclinical research applications.
Quick answer
Nicotinamide adenine dinucleotide (NAD+) is an essential pyridine nucleotide coenzyme involved in fundamental cellular bioenergetics, redox homeostasis, and enzymatic signaling. PX1 Research provides high-purity NAD+ research compound exclusively for laboratory research use, supporting rigorous in vitro and preclinical research applications.
Key takeaways
- The [NAD+](/research-peptides/nad-plus) research compound (nicotinamide adenine dinucleotide) is a critical pyridine nucleotide coenzyme supplied for in vitro and preclinical laboratory research.
- At the molecular level, [NAD+](/research-peptides/nad-plus) functions as an essential electron acceptor in catabolic pathways, undergoing reversible reduction to form NADH.
- Unlike its reversible role in redox reactions, [NAD+](/research-peptides/nad-plus) is consumed as a co-substrate by several key classes of regulatory enzymes.
- Preclinical studies suggest that intracellular [NAD+](/research-peptides/nad-plus) concentration declines with age across various rodent tissue models, leading to impaired mitochondrial respiration, diminished nuclear-mitochondrial communication, and altered metabolic flux.
Defining the NAD+ Research Compound
The NAD+ research compound (nicotinamide adenine dinucleotide) is a critical pyridine nucleotide coenzyme supplied for in vitro and preclinical laboratory research. It serves as an essential electron carrier in cellular respiration and acts as a substrate for NAD+-dependent enzymes including sirtuins (SIRT1–7) and poly(ADP-ribose) polymerases (PARPs).
In academic and pharmaceutical research environments, researchers utilize the NAD+ research compound to evaluate cellular metabolic activity, mitochondrial function, enzymatic kinetics, and signaling cascades linked to metabolic homeostasis. Available as a purified biochemical solid, this compound allows researchers to precisely control experimental conditions in cell culture, tissue homogenates, and enzymatic assays.
To ensure precise experimental reproducibility, high-purity standards are vital. Investigating metabolic pathways requires materials verified by high-performance liquid chromatography (HPLC) and mass spectrometry (MS), preventing batch-to-batch variation or chemical artifacts from compromising experimental assays across our full catalog of research peptides.
Biochemical Mechanism of Action and Cellular Energetics
At the molecular level, NAD+ functions as an essential electron acceptor in catabolic pathways, undergoing reversible reduction to form NADH. This interconversion between oxidized (NAD+) and reduced (NADH) states drives glycolysis, the tricarboxylic acid (TCA) cycle, and mitochondrial beta-oxidation.
In the inner mitochondrial membrane, NADH donates high-energy electrons to Complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain (ETC). This electron transfer fuels proton translocation across the inner membrane, establishing the electrochemical gradient necessary for ATP synthesis via ATP synthase.
Beyond its role as a redox co-factor, the steady-state ratio of intracellular NAD+ to NADH serves as a central metabolic sensor. Fluctuations in the NAD+/NADH ratio modulate cellular bioenergetics, gene expression, and enzyme kinetics under experimental stressors such as nutrient deprivation or hypoxia.
NAD+ as an Enzymatic Substrate: Sirtuins, PARPs, and CD38
Unlike its reversible role in redox reactions, NAD+ is consumed as a co-substrate by several key classes of regulatory enzymes. Sirtuins (SIRT1 through SIRT7) are NAD+-dependent protein deacetylases that remove acetyl groups from lysine residues on target proteins, regulating chromatin remodeling, transcription factor activity, and mitochondrial biogenesis.
Poly(ADP-ribose) polymerases (PARPs), primarily PARP1 and PARP2, consume NAD+ to synthesize poly(ADP-ribose) chains on target nuclear proteins during DNA damage response pathways. High levels of genomic stress lead to rapid PARP activation and subsequent depletion of cellular NAD+ pools in vitro.
Additionally, membrane-bound ectoenzymes such as CD38 and CD157 function as NAD+ hydrolases, converting NAD+ into cyclic ADP-ribose (cADPR) and nicotinamide (NAM). Researchers frequently measure CD38 activity to study age-related alterations in intracellular NAD+ degradation pathways in preclinical animal models.
Preclinical Literature Findings: Mitochondrial Bioenergetics and Aging
Preclinical studies suggest that intracellular NAD+ concentration declines with age across various rodent tissue models, leading to impaired mitochondrial respiration, diminished nuclear-mitochondrial communication, and altered metabolic flux. In vitro data indicate that supplementing culture media with exogenous NAD+ or its immediate metabolites restores mitochondrial membrane potential and enhances oxidative phosphorylation capacities in primary cell cultures.
Animal study models investigating neurodegenerative pathways have demonstrated that maintaining nuclear and axonal NAD+ levels protects against axotomy-induced axonal degeneration (Wallerian degeneration). In these models, NAD+ availability supports the activity of NMNAT1 and NMNAT2 (nicotinamide mononucleotide adenylyltransferases), preserving structural axonal integrity under experimental stress.
Furthermore, rodent models evaluating metabolic dysregulation indicate that modulation of NAD+ availability influences hepatic glucose production, lipid accumulation, and skeletal muscle insulin sensitivity. These findings position the NAD+ research compound as a foundational tool for mapping metabolic signaling networks in vitro.
Comparative Analysis: NAD+ vs. Precursors and Mitochondrial Compounds
When designing metabolic experiments, researchers often compare direct NAD+ administration against precursor molecules and mitochondrial targeting compounds. Precursor molecules like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) bypass extracellular enzymatic barriers via dedicated transporters (e.g., Slc12a8 for NMN) before being converted into intracellular NAD+ through the salvage pathway.
In contrast to precursor nucleotides, direct evaluation of the NAD+ research compound allows researchers to bypass enzymatic rate-limiting steps in cell-free systems or permeabilized cell models. When evaluating broader mitochondrial function, investigators frequently compare NAD+ responses to mitochondrial-derived peptides like MOTS-c, which acts on nuclear transcription during metabolic stress, and SS-31, which directly targets cardiolipin in the inner mitochondrial membrane.
Additionally, researchers targeting specific enzyme systems may pair NAD+ supplementation assays with small molecule inhibitors like 5-Amino-1MQ, an NNMT inhibitor that preserves methyl donors and indirectly influences NAD+ synthesis pathways. Understanding these distinct pathways helps laboratories select the optimal compounds for their specific research paradigms.
Reconstitution, Handling, and Storage Protocols for Laboratory Use
Proper reconstitution and handling protocols are essential to maintain the biochemical integrity of the NAD+ research compound. NAD+ is susceptible to temperature-dependent degradation and hydrolytic cleavage in aqueous solutions, particularly at elevated temperatures or non-neutral pH conditions.
For optimal stability, lyophilized NAD+ powder should be stored at -20°C or -80°C in a desiccated environment. Reconstitution should be performed using sterile, nuclease-free water or appropriate physiological buffers (such as PBS) at pH 7.0–7.4 immediately prior to experimental application.
Once reconstituted, aqueous NAD+ solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles. Aliquots kept at -80°C remain stable for limited durations, while working solutions maintained at 4°C should be utilized within hours to avoid chemical breakdown into nicotinamide and ADP-ribose.
Analytical Quality Control: HPLC, MS, and Endotoxin Verification
In scientific research, assay integrity depends directly on compound purity. Impurities or degradation products such as free nicotinamide or residual organic solvents can inhibit enzymatic activity or introduce cytotoxic artifacts into primary cell culture experiments.
PX1 Research enforces strict analytical standards for every lot of NAD+ supplied. Each batch undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm structural purity exceeding 98%. Electrospray Ionization Mass Spectrometry (ESI-MS) is utilized to verify the exact molecular mass (663.43 g/mol) and structural identity.
To protect cell cultures from inflammatory signaling contamination, each lot undergoes Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels (<0.01 EU/mg). A batch-specific Certificate of Analysis (COA) is accessible with every order, providing complete analytical transparency for institutional audits.
Sourcing Standards for Institutional and Research Accounts
Evaluating research compound suppliers requires verifying manufacturing compliance, analytical rigor, and domestic supply chain transparency. Low-tier reagents sourced without stringent lot testing carry significant risk of batch variability, chemical contamination, or mislabeled concentrations.
PX1 Research manufactures and processes compounds within ISO 17025 accredited and GMP-compliant facilities in the United States. With dual fulfillment hubs located in California and Arizona, PX1 provides same-day shipping (Monday–Friday) to prevent transit delays and maintain compound integrity.
For university laboratories, biotechnology enterprises, and clinical research institutions conducting large-scale screening assays, PX1 provides transparent bulk pricing and dedicated support through our PX1 Wholesale Services. Our commitment to pure, rigorously tested compounds ensures reproducible data across every trial.
Frequently Asked Questions
What is the primary function of NAD+ in laboratory research?
The NAD+ research compound is used in laboratory settings to study cellular bioenergetics, mitochondrial electron transport, sirtuin-mediated deacetylation, PARP DNA repair activity, and metabolic signaling pathways in cell culture and cell-free assays.
How should lyophilized NAD+ powder be stored in the lab?
Lyophilized NAD+ powder should be stored at -20°C or -80°C in a desiccated container protected from light. Under these conditions, the compound maintains stability for long-term research storage.
What solvent is recommended for reconstituting NAD+ for in vitro assays?
NAD+ should be reconstituted in sterile, nuclease-free water or standard physiological buffers like PBS (pH 7.0–7.4). Solubilization should occur immediately prior to experimental use to minimize hydrolytic breakdown.
How does PX1 Research verify the purity of its NAD+ research compound?
Every lot of NAD+ at PX1 Research is tested via RP-HPLC for chemical purity (≥98%), ESI-MS for mass identity verification, and LAL assays for endotoxin quantification. A lot-specific Certificate of Analysis (COA) is provided.
Is NAD+ stable in aqueous solutions at room temperature?
No, aqueous solutions of NAD+ undergo slow hydrolysis at room temperature and elevated pH. Reconstituted stock solutions should be kept on ice during experiments and stored at -80°C in single-use aliquots.
What is the molecular weight of NAD+?
Nicotinamide adenine dinucleotide (NAD+) has a molecular formula of C21H27N7O14P2 and a formula weight of approximately 663.43 g/mol.
Can NAD+ be used for human administration or clinical therapy?
No. All products offered by PX1 Research, including NAD+, are sold strictly for laboratory research use only (in vitro and preclinical investigation). They are not for human or animal diagnostic, therapeutic, or medical application.
How does NAD+ differ from NMN in experimental designs?
NAD+ is the active coenzyme utilized directly by sirtuins and PARPs. NMN is a precursor mononucleotide that must be converted into NAD+ by intracellular NMNAT enzymes, making direct NAD+ application preferable for cell-free or permeabilized cell enzymatic assays.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.